Core Laboratories Inc (CLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | 09-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 25,307 | 29,548 | 23,253 | 25,088 | 22,204 |
| Receivables | 210,810 | 214,853 | 218,182 | 206,616 | 209,480 |
| Inventories | 49,451 | 51,392 | 50,906 | 46,821 | 53,646 |
| Other current assets | 11,302 | 11,557 | 11,151 | 12,215 | 9,193 |
| TOTAL | $311,268 | $322,242 | $318,508 | $303,868 | $307,828 |
| Non-Current Assets | |||||
| PPE Net | 146,951 | 143,926 | 141,758 | 138,824 | 135,001 |
| Intangibles | 175,339 | 175,374 | 175,331 | 174,286 | 174,173 |
| Other Non-Current Assets | 51,574 | 47,586 | 44,766 | 44,032 | 40,474 |
| TOTAL | $373,864 | $366,886 | $361,855 | $357,142 | $349,648 |
| Total Assets | $685,132 | $689,128 | $680,363 | $661,010 | $657,476 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 49,648 | 51,292 | 53,715 | 50,821 | 53,901 |
| Accrued Expenses | 34,096 | 34,266 | 27,084 | 38,969 | 35,318 |
| TOTAL | $127,037 | $133,924 | $148,461 | $135,775 | $137,830 |
| Non-Current Liabilities | |||||
| Long Term Debt | 370,000 | 333,000 | 279,000 | 267,002 | 256,007 |
| Deferred Revenues | 11,045 | 11,844 | 17,481 | 10,887 | 12,507 |
| Other Non-Current Liabilities | 80,482 | 82,331 | 81,178 | 79,982 | 74,166 |
| TOTAL | $456,320 | $418,923 | $364,968 | $355,846 | $335,355 |
| Total Liabilities | $583,357 | $552,847 | $513,429 | $491,621 | $473,185 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 43,797 | 44,421 | 44,876 | 44,856 | 45,365 |
| Common Shares | 1,174 | 1,203 | 1,203 | 1,203 | 1,203 |
| Retained earnings | 384,335 | 495,792 | 454,503 | 415,930 | 370,905 |
| Other shareholders' equity | -1,747 | -2,405 | -2,729 | -2,744 | -1,817 |
| TOTAL | $101,775 | $136,281 | $166,934 | $169,389 | $184,291 |
| Total Liabilities And Equity | $685,132 | $689,128 | $680,363 | $661,010 | $657,476 |